Market revenue in 2023 | USD 46,914.3 million |
Market revenue in 2030 | USD 120,780.8 million |
Growth rate | 14.5% (CAGR from 2023 to 2030) |
Largest segment | Therapeutics |
Fastest growing segment | Diagnostics |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Diagnostics, Therapeutics |
Key market players worldwide | Roche, Siemens Healthineers AG ADR, Janssen Pharmaceuticals, Illumina Inc, Quest Diagnostics Inc, 23andMe Holding Co Class A, NeoDiagnostix, International Business Machines Corp, Myriad Genetics Inc, Medtronic PLC, GE HealthCare Technologies Inc Common Stock, Abbott Laboratories, Dakota Software, Biogen Inc, Qiagen NV, ImmunityBio Inc Ordinary Shares |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to precision medicine market will help companies and investors design strategic landscapes.
Therapeutics was the largest segment with a revenue share of 85.61% in 2023. Horizon Databook has segmented the North America precision medicine market based on diagnostics, therapeutics covering the revenue growth of each sub-segment from 2018 to 2030.
The National Institutes of Health’s National Human Genome Research Institute (NHGRI) highlights that most medical treatments are designed for the general population with a “one size fits all” approach, which, while effective for many, does not benefit all patients equally.
Personalized medicine, also known as precision medicine, is an emerging and promising practice that uses an individual’s genetic profile to help clinicians determine the best approaches for preventing, diagnosing, treating, and managing specific diseases & conditions.
This tailored approach can also assist in prescribing the most suitable medication or therapy and dosage for individual patients. According to the Personalized Medicine Coalition (PMC), personalized medicine has the prospective to improve treatment outcomes for various diseases through targeted therapies, enhancing the overall effectiveness of medicine.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America precision medicine market , including forecasts for subscribers. This continent databook contains high-level insights into North America precision medicine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account